RT Journal Article
SR Electronic
T1 Review of Biosafety Guidelines
JF PDA Journal of Pharmaceutical Science and Technology
JO PDA J Pharm Sci Technol
FD Parenteral Drug Association (PDA)
SP 252
OP 258
VO 43
IS 6
YR 1989
UL http://journal.pda.org/content/43/6/252.abstract
AB The increased use of recombinant DNA technology, human cell lines, and other human-source materials in the production of pharmaceutical products, has brought to the fore concern for the protection of our employees. A number of guidelines are available that cover “biosafety” issues and are reviewed in this article.